LINCOSAMIDE
ANTIBIOTICS
Anusha Shaji, B.Pharm, M.Pharm
Assistant Professor
Department of Pharmacology
Nirmala College of Pharmacy,
Muvattupuzha, Ernakulam
CLINDAMYCIN
Potent lincosamide antibiotic
MOA: Inhibit protein synthesis by binding to 50s ribosome
Similar in spectrum of activity to erythromycin
Clindamycin inhibits most gram positive cocci, C. diphtheriae,
Nocardia, Actinomyces and Toxoplasma
It has slow action on Plasmodia
Pharmacokinetics
Oral absorption of clindamycin is good
It penetrates into most skeletal and soft tissues, but not in brain and
CSF
Accumulates in neutrophils and macrophages
It is largely metabolized and metabolites are excreted in urine and bile
Plasma half life: 3 hours
Side effects
Rashes, urticaria and abdominal pain
Diarrhoea
Pseudomembranous enterocolitis due to Clostridium difficile
superinfection which is potentially fatal → the drug should be promptly
stopped and oral metronidazole (alternatively vancomycin) given to treat
it
Thrombophlebitis of the injected vein can occur on i.v. administration
Uses
Because of the potential toxicity → use of clindamycin is restricted to
anaerobic and mixed infections
Used for Bact. fragilis causing abdominal, pelvic and lung abscesses
↓
It is a first line drug for these conditions, and is generally combined
with an aminoglycoside or a cephalosporin
Metronidazole and chloramphenicol are the alternatives to
clindamycin for covering the anaerobes
Skin and soft tissue infections in patients allergic to penicillins can be
treated with clindamycin
LINCOMYCIN
It is the forerunner of clindamycin
Similar antibacterial and toxic properties
Less potent and produces a higher incidence of diarrhoea and colitis-
death have occured
↓
Thus, it has been largely replaced by clindamycin
Pharmacokinetics
It is absorbed orally and excreted mainly in bile
Plasma half life: 5 hours
Dose: 500 mg TDS-QID oral, 600 mg i.m. or by i.v. infusion 6-12
hrly
Lincosamides

Lincosamides

  • 1.
    LINCOSAMIDE ANTIBIOTICS Anusha Shaji, B.Pharm,M.Pharm Assistant Professor Department of Pharmacology Nirmala College of Pharmacy, Muvattupuzha, Ernakulam
  • 2.
    CLINDAMYCIN Potent lincosamide antibiotic MOA:Inhibit protein synthesis by binding to 50s ribosome Similar in spectrum of activity to erythromycin Clindamycin inhibits most gram positive cocci, C. diphtheriae, Nocardia, Actinomyces and Toxoplasma It has slow action on Plasmodia Pharmacokinetics Oral absorption of clindamycin is good It penetrates into most skeletal and soft tissues, but not in brain and CSF
  • 3.
    Accumulates in neutrophilsand macrophages It is largely metabolized and metabolites are excreted in urine and bile Plasma half life: 3 hours Side effects Rashes, urticaria and abdominal pain Diarrhoea Pseudomembranous enterocolitis due to Clostridium difficile superinfection which is potentially fatal → the drug should be promptly stopped and oral metronidazole (alternatively vancomycin) given to treat it Thrombophlebitis of the injected vein can occur on i.v. administration
  • 4.
    Uses Because of thepotential toxicity → use of clindamycin is restricted to anaerobic and mixed infections Used for Bact. fragilis causing abdominal, pelvic and lung abscesses ↓ It is a first line drug for these conditions, and is generally combined with an aminoglycoside or a cephalosporin Metronidazole and chloramphenicol are the alternatives to clindamycin for covering the anaerobes Skin and soft tissue infections in patients allergic to penicillins can be treated with clindamycin
  • 5.
    LINCOMYCIN It is theforerunner of clindamycin Similar antibacterial and toxic properties Less potent and produces a higher incidence of diarrhoea and colitis- death have occured ↓ Thus, it has been largely replaced by clindamycin Pharmacokinetics It is absorbed orally and excreted mainly in bile Plasma half life: 5 hours Dose: 500 mg TDS-QID oral, 600 mg i.m. or by i.v. infusion 6-12 hrly